Table ΙΙ.
Characteristics of sperm nuclear integrity in groups
| Control (C) | 40Sc/7D (sc 1) | 200Sc/7D (Sc 2) | 40Sc/35D (Sc 3) | 200Sc/35D (Sc 4) | 40Au/7D (Au 1) | 200Au/7D (Au 2) | 40Au/35 (Au 3) | 200Au/35 (Au 4) | p-value | |
|---|---|---|---|---|---|---|---|---|---|---|
| AB- | 98.13±1.45 | 94.75±3.32 | 96.25±2.55 | 97.50±1.41 | 96.75±1.58 | 94.63±2.20 | 98.13±1.64 | 95.00±2.72 | 93.00±2.13 | 0.000 |
| TB- | 98.25±2.76 | 92.38±3.85 | 94.25±2.31 | 98.00±1.41 | 96.88±3.22 | 91.38±6.88 | 96.00±5.01 | 96.50±2.00 | 95.00±2.00 | 0.003 |
| CMA3- | 99.75±0.46 | 97.50±1.51 | 97.88±2.90 | 100.00±0.00 | 99.63±0.51 | 97.38±2.20 | 99.75±0.46 | 98.50±1.06 | 97.13±1.45 | 0.000 |
P<0.05 represents a significant difference between groups. All data are present as mean ±SD.
D: treatment days Sc: sham group Au: experimental group